Tähelepanu! Artikkel on enam kui 5 aastat vana ning kuulub väljaande digitaalsesse arhiivi. Väljaanne ei uuenda ega kaasajasta arhiveeritud sisu, mistõttu võib olla vajalik kaasaegsete allikatega tutvumine
Pfizer to acquire Coley Pharmaceutical Group
(BW)(PFIZER-1-2-3-4-5-6)(PFE)(COLY) Pfizer to Acquire Coley Pharmaceutical Group
Acquisition Will Expand Pfizer's Investment in Vaccines- Broaden
Scope of Research in a Number of Key Therapeutic
AreasBusiness Editors/Healthcare
Editors
<em><br /></em>NEW YORK amp; WELLESLEY- Mass.--(BUSINESSWIRE)--Nov. 16- 2007--Pfizer Inc (NYSE: PFE) announced today it hasentered into an agreement to acquire Coley Pharmaceutical Group-Inc. (NASDAQ: COLY)- a publicly-held biopharmaceutical companyspecializing in vaccine adjuvant technology and a new class ofimmunomodulatory drug candidates designed to fight cancers- allergyand asthma disorders- and autoimmune diseases.